Burn Quality
    Capital allocation
    Investor readiness
    Decision gates

    Beyond Burn Rate: Burn Quality (BQ) for Smarter Capital Allocation

    Burn rate measures speed. Burn Quality measures value per euro. Use ΔPoS × Value at Gate / € Spent to fund milestones that retire risk and raise valuations.

    September 24, 2025
    6 min read

    In life sciences, managing cash is critical. But burn rate only tells you how fast you spend- not what you create. Burn Quality (BQ) is a simple way to compare uses of cash and fund milestones that reduce risk and build value on schedule.

    What is burn quality?

    Burn Quality quantifies the capital efficiency of a strategic decision (experiment, milestone, or hire). It lets you compare options and pick the ones that create the most value per euro.

    Formula

    BQ = (ΔPoS × Value at Gate) / € Spent
    • ΔPoS (Change in Probability of Success): improvement in likelihood of success after the activity (e.g., 10%→25% gives ΔPoS = 0.15).
    • Value at Gate: the financeable value once you reach the milestone (e.g., clinical pilots signed, IND enabled, data package accepted).
    • € Spent: fully loaded cost to reach that gate.

    Like what you're reading?

    Subscribe for more strategic notes on biotech and venture design.

    How to interpret BQ

    • BQ > 1 → every euro spent creates more than one euro of risk-adjusted value.
    • BQ < 1 → deprioritise or redesign the activity.

    Examples

    • A therapeutics team calculated BQ = 3.75 for tox studies → clear priority over other activities.
    • A platform company compared options: deepen the lead (BQ = 2.4) vs. start a new indication (BQ = 1.0) → deepen first.
    Investors don't buy runway; they buy a schedule of decreasing risk. Sharing your BQ for competing options shows discipline, earns credibility, and aligns your ask with value creation.

    Take aways

    • Fund gates, not generic activity.
    • Prioritise by risk retired per euro.
    • Communicate BQ to align founders, board, and investors.

    Need a BQ worksheet? Book a call and I'll set up your model in one session.

    Investors don't fund activities; they fund value inflection points. Let's align your next round's ask with a strategic capital allocation plan.

    Structure your capital strategy

    Worth reading. Worth keeping.

    Strategic notes on biotech fundraising and venture design. When there is something worth saying. Unsubscribe anytime.

    Related Insights

    fundraising

    The ask is not a budget. It's a value proposition.

    7 min read
    risk

    The uncertainty map: how to find the one risk holding your asset's value hostage

    7 min read
    venture building

    What is freedom to operate in biotech and why investors ask about it first

    12 min read